Banque Pictet & Cie’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-246
Closed -$188K 419
2025
Q3
$188K Buy
+246
New +$183K ﹤0.01% 391
2025
Q1
Sell
-204
Closed -$157K 409
2024
Q4
$157K Sell
204
-362
-64% -$300K ﹤0.01% 321
2024
Q3
$502K Buy
+566
New +$509K ﹤0.01% 261

Other funds holding LLY

Banque Pictet & Cie's LLY Position: Q2 2026 in Review

Banque Pictet & Cie increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $2.8M and bringing the position to 67,095 shares worth $80.5M. The position accounts for 0.5% of the portfolio, ranked #31.

Banque Pictet & Cie first reported a position in LLY in Q4 2013 and has held it in 42 quarters since. 3,496 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Banque Pictet & Cie held 67,095 shares of Eli Lilly worth $80.5M as of Q2 2026.
  • Banque Pictet & Cie bought 2,741 Eli Lilly shares in Q2 2026, an estimated $2.8M.
  • Eli Lilly made up 0.5% of Banque Pictet & Cie's portfolio in Q2 2026, its #31 holding.
  • Banque Pictet & Cie first reported a position in Eli Lilly in Q4 2013 and has held it in 42 quarters since.
  • 3,496 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.